Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration
Authors:
Open Access
- 19 October 2023
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 25 (1) , 1-14
Abstract
Background: In European axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) clinical registries, we aimed to investigate commonalities and differences in (1) set-up, clinical data collection; (2) data availability and completeness; and (3) wording, recall period, and scale used for selected patient-reported outcome measures (PROMs). Methods: Data was obtained as part of the EuroSpA Research Collaboration Network and consisted of (1) an online survey and follow-up interview, (2) upload of real-world data, and (3) selected PROMs included in the online survey. Results: Fifteen registries participated, contributing 33,948 patients (axSpA: 21,330 (63%), PsA: 12,618 (37%)). The reported coverage of eligible patients ranged from 0.5 to 100%. Information on age, sex, biological/targeted synthetic disease-modifying anti-rheumatic drug treatment, disease duration, and C-reactive protein was available in all registries with data completeness between 85% and 100%. All PROMs (Bath Ankylosing Spondylitis Disease Activity and Functional Indices, Health Assessment Questionnaire, and patient global, pain and fatigue assessments) were more complete after 2015 (68–86%) compared to prior (50–79%). Patient global, pain and fatigue assessments showed heterogeneity between registries in terms of wording, recall periods, and scale. Conclusion: Important heterogeneity in registry design and data collection across fifteen European axSpA and PsA registries was observed. Several core measures were widely available, and an increase in data completeness of PROMs in recent years was identified. This study might serve as a basis for examining how differences in data collection across registries may impact the results of collaborative research in the future.Keywords
Funding Information
- Novartis Pharma AG
- Royal Library, Copenhagen University Library
This publication has 45 references indexed in Scilit:
- Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIORheumatology, 2014
- Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validationClinical Rheumatology, 2011
- European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projectsAnnals of the Rheumatic Diseases, 2011
- Translation, adaptation and validation of instruments or scales for use in cross‐cultural health care research: a clear and user‐friendly guidelineJournal of Evaluation in Clinical Practice, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Measuring fatigue in rheumatoid arthritis: A systematic review of scales in useArthritis Care & Research, 2007
- Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into DanishScandinavian Journal of Rheumatology, 2007
- Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse eventsRheumatology International, 2006
- The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validityScandinavian Journal of Rheumatology, 1999
- The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validityScandinavian Journal of Rheumatology, 1999